NIH – MPP, COVID-19 Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement
Boston University Startup Exclusive License Template Post author:GHIAA Admin Post published:June 6, 2022 Post category: Continue ReadingBoston University Startup Exclusive License Template
Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement Post author:GHIAA Admin Post published:May 31, 2022 Post category: Continue ReadingElkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement
BMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:April 26, 2022 Post category: Continue ReadingBMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement
Gavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement Post author:GHIAA Admin Post published:April 12, 2022 Post category: Continue ReadingGavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Admin Post published:March 31, 2022 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
CEPI – Dynavax, COVID-19 Material Reservation Agreement Post author:GHIAA Admin Post published:January 28, 2022 Post category: Continue ReadingCEPI – Dynavax, COVID-19 Material Reservation Agreement
University of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement Post author:GHIAA Admin Post published:January 11, 2022 Post category: Continue ReadingUniversity of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement
MSD – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 22, 2021 Post category: Continue ReadingMSD – MPP, Molnupiravir License Agreement